-
Something wrong with this record ?
A synergy of liquid chromatography with high-resolution mass spectrometry and coagulation test for determination of direct oral anticoagulants for clinical and toxicological purposes
V. Maier, L. Slavík, P. Ondra
Language English Country Great Britain
Document type Journal Article
Grant support
FNOl 00098892
Ministry of Health, Czech Republic - conceptual development of research organization
PubMed
34109658
DOI
10.1002/bmc.5195
Knihovny.cz E-resources
- MeSH
- Anticoagulants * administration & dosage blood isolation & purification toxicity MeSH
- Administration, Oral MeSH
- Chromatography, Liquid methods MeSH
- Mass Spectrometry methods MeSH
- Humans MeSH
- Linear Models MeSH
- Reproducibility of Results MeSH
- Sensitivity and Specificity MeSH
- Blood Coagulation Tests methods MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Direct oral anticoagulants are an alternative to anticoagulants based on vitamin K antagonists. Monitoring of direct oral anticoagulant concentration levels is necessary in specific cases (e.g. in emergency conditions, for determination of the cause of bleeding, adverse effects, risk of drug-direct oral anticoagulants interaction); therefore, a sensitive and specific method is needed. A methanol protein precipitation method followed by liquid chromatography with high-resolution mass spectrometry was developed for simultaneous separation and determination of apixaban, betrixaban, edoxaban, dabigatran, rivaroxaban and ximelagatran. The proposed method was fully validated in terms of linearity, the limits of detection and quantification, intra- and inter-day trueness and precision, recovery, matrix effect, process efficiency and stability. The method shows a strong correlation (Pearson's correlation coefficients > 0.92) with coagulation assays of apixaban, dabigatran and rivaroxaban (dilute thrombin time for gatrans and anti Xa factor (anti-Xa) activity for xabans). In addition, the developed method was applied for the identification and determination of apixaban and dabigatran in post-mortem serum samples. The developed method is a good alternative to coagulation tests which may show various interferences.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22003535
- 003
- CZ-PrNML
- 005
- 20220127150127.0
- 007
- ta
- 008
- 220113s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/bmc.5195 $2 doi
- 035 __
- $a (PubMed)34109658
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Maier, Vítězslav $u Department of Forensic Medicine and Medical Law, Faculty of Medicine and Dentistry, Palacký University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic
- 245 12
- $a A synergy of liquid chromatography with high-resolution mass spectrometry and coagulation test for determination of direct oral anticoagulants for clinical and toxicological purposes / $c V. Maier, L. Slavík, P. Ondra
- 520 9_
- $a Direct oral anticoagulants are an alternative to anticoagulants based on vitamin K antagonists. Monitoring of direct oral anticoagulant concentration levels is necessary in specific cases (e.g. in emergency conditions, for determination of the cause of bleeding, adverse effects, risk of drug-direct oral anticoagulants interaction); therefore, a sensitive and specific method is needed. A methanol protein precipitation method followed by liquid chromatography with high-resolution mass spectrometry was developed for simultaneous separation and determination of apixaban, betrixaban, edoxaban, dabigatran, rivaroxaban and ximelagatran. The proposed method was fully validated in terms of linearity, the limits of detection and quantification, intra- and inter-day trueness and precision, recovery, matrix effect, process efficiency and stability. The method shows a strong correlation (Pearson's correlation coefficients > 0.92) with coagulation assays of apixaban, dabigatran and rivaroxaban (dilute thrombin time for gatrans and anti Xa factor (anti-Xa) activity for xabans). In addition, the developed method was applied for the identification and determination of apixaban and dabigatran in post-mortem serum samples. The developed method is a good alternative to coagulation tests which may show various interferences.
- 650 _2
- $a aplikace orální $7 D000284
- 650 12
- $a antikoagulancia $x aplikace a dávkování $x krev $x izolace a purifikace $x toxicita $7 D000925
- 650 _2
- $a vyšetření krevní srážlivosti $x metody $7 D001780
- 650 _2
- $a chromatografie kapalinová $x metody $7 D002853
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lineární modely $7 D016014
- 650 _2
- $a hmotnostní spektrometrie $x metody $7 D013058
- 650 _2
- $a reprodukovatelnost výsledků $7 D015203
- 650 _2
- $a senzitivita a specificita $7 D012680
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Slavík, Luděk $u Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacký University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Ondra, Peter $u Department of Forensic Medicine and Medical Law, Faculty of Medicine and Dentistry, Palacký University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic
- 773 0_
- $w MED00000817 $t Biomedical chromatography : BMC $x 1099-0801 $g Roč. 35, č. 10 (2021), s. e5195
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34109658 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127150123 $b ABA008
- 999 __
- $a ok $b bmc $g 1751097 $s 1154684
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 35 $c 10 $d e5195 $e 20210621 $i 1099-0801 $m BMC. Biomedical chromatography $n Biomed Chromatogr $x MED00000817
- GRA __
- $a FNOl 00098892 $p Ministry of Health, Czech Republic - conceptual development of research organization
- LZP __
- $a Pubmed-20220113